# Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy

> **NCT03275337** · NA · COMPLETED · sponsor: **Laureate Institute for Brain Research, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Anxiety Disorders
- Social Phobia

## Interventions

- **DEVICE:** Transcranial Direct Current Stimulation

## Key facts

- **NCT ID:** NCT03275337
- **Lead sponsor:** Laureate Institute for Brain Research, Inc.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03275337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03275337, "Cerebellar Neuromodulation to Enhance Fear Extinction and Predict Response to Exposure Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03275337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*